 CD4 Lymphocyte Count
"CD4 Lymphocyte Count" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.
| Descriptor ID |
D018791
|
| MeSH Number(s) |
E01.370.225.500.195.107.595.500.150 E01.370.225.625.107.595.500.150 E05.200.500.195.107.595.500.150 E05.200.625.107.595.500.150 E05.242.195.107.595.500.150 G04.170.107.595.500.150 G09.188.105.595.500.150
|
| Concept/Terms |
CD4 Lymphocyte Count- CD4 Lymphocyte Count
- Lymphocyte Count, CD4
- CD4 Lymphocyte Counts
- Lymphocyte Counts, CD4
- CD4 Counts
- CD4 Count
- CD4 Cell Counts
- CD4 Cell Count
- CD4+ Cell Counts
- CD4+ Cell Count
- CD4+ Counts
- CD4+ Count
- T4 Lymphocyte Count
- Count, T4 Lymphocyte
- Counts, T4 Lymphocyte
- Lymphocyte Count, T4
- Lymphocyte Counts, T4
- T4 Lymphocyte Counts
|
Below are MeSH descriptors whose meaning is more general than "CD4 Lymphocyte Count".
Below are MeSH descriptors whose meaning is more specific than "CD4 Lymphocyte Count".
This graph shows the total number of publications written about "CD4 Lymphocyte Count" by people in this website by year, and whether "CD4 Lymphocyte Count" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "CD4 Lymphocyte Count" by people in Profiles.
-
Nyanhete TE, Edwards RJ, LaBranche CC, Mansouri K, Eaton A, Dennison SM, Saunders KO, Goodman D, Janowska K, Spreng RL, Zhang L, Mudrak SV, Hope TJ, Hora B, Bradley T, Georgiev IS, Montefiori DC, Acharya P, Tomaras GD. Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers. Front Immunol. 2021; 12:670561.
-
Wilson D, Goggin K, Williams K, Gerkovich MM, Gqaleni N, Syce J, Bartman P, Johnson Q, Folk WR. Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial. PLoS One. 2015; 10(7):e0128522.
-
Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation. Pediatrics. 2014 Oct; 134(4):e1104-16.
-
Uy J, Brooks JT, Baker R, Hoffman M, Moorman A, Novak R. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement? Antivir Ther. 2007; 12(6):957-62.
-
Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS. 1998 May 28; 12(8):F65-70.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|